nocita.aratana.comNocita® for Dogs and Cats | Long-acting pain relief

Pet Owners Farm Animal Professionals Log In Log In Home Products Show submenu forProducts ” Dermatology Show submenu forDermatology ” Atopica® for Cats (cyclosporine oral solution) USP MODIFIED Atopica® (cyclosporine capsules) USP MODIFIED for Dogs Baytril® Otic (enrofloxacin/silver sulfadiazine) Emulsion Claro® (florfenicol, terbinafine, mometasone furoate) Otic Solution Surolan® (miconazole nitrate, polymyxin B sulfate, prednisolone acetate) Veraflox® (pradofloxacin) Disease Management Show submenu forDisease Management ” Baytril® (enrofloxacin) Antibacterial Injectable Solution Baytril® (enrofloxacin) Antibacterial Tablets Bexacat™ (bexagliflozin tablets) Elura® (capromorelin oral solution) Entyce® (capromorelin oral solution) Percorten®-V (desoxycorticosterone pivalate injectable suspension) Tanovea® (rabacfosadine for injection) Varenzin™-CA1 (molidustat oral suspension) Canine Parvovirus mAb Vaccine Show submenu forVaccine ” TruCan™ for Dogs TruFel™ for Cats Rabvac® Parasitology Show submenu forParasitology ” Advantage Multi® for Cats (imidacloprid + moxidectin) Advantage Multi® for Dogs (imidacloprid + moxidectin) Advantage® II for Cats Advantage® II for Dogs Credelio® CAT (lotilaner) Credelio® (lotilaner) for Dogs Droncit® (praziquantel) Interceptor® Plus (milbemycin oxime/praziquantel) K9 Advantix® II for Dogs Profender® (emodepside/praziquantel) Seresto® for Cats Seresto® for Dogs Trifexis® (spinosad + milbemycin oxime) Pain Management Show submenu forPain Management ” Pain Portfolio Deramaxx® (deracoxib) Galliprant® (grapiprant tablets) Nocita® (bupivacaine liposome injectable suspension) Onsior® (robenacoxib) quellin® (carprofen) Zorbium® (buprenorphine transdermal solution) Vetspon® Education Show submenu forEducation ” Upcoming Events Elanco CE Courses Sponsored CE Courses Educational Articles Practice Management Support Resources Contact Services FAQs Pet Owners Farm Animal Professionals Why Choose Nocita Product Information Dosing and Administration Resources Nocita®(bupivacaine liposome injectable suspension) Pain and dysphoria don’t have to be part of the post-op experience.* See the difference with Nocita, the only long-acting local anesthetic that controls post-op pain for up to 72 hours. *In a field trial, Nocita reduced the need for post-op rescue pain treatment with opioids. Product Label Why Choose Nocita? Up to 72-hour analgesia Controls pain to help post-op return to function Single-dose administration Less opioid use 1 Reduced opioid-associated side effects, including dysphoria Discharge patients sooner, possibly equalizing or reducing cost of care Potentially improving client satisfaction Helps patients recover comfortably even after they have gone home Nocita Product Information Indication For relief of pain in dogs following CCL surgery and as a peripheral nerve block to provide regional postoperative analgesia following onychectomy in cats. Formulation Injection Active ingredients Bupivacaine liposome injectable suspension How to Administer Nocita in Dogs icon-expand Play Close How to Administer Nocita in Cats Administer 5.3 mg/kg per forelimb (0.4 mL/kg per forelimb, for a total dose of 10.6 mg/kg/cat) as a 4-point nerve block prior to onychectomy. A: 0.14 mL/kg (35%) Superficial Branch of the Radial Nerve At the center of the limb, on the dorsal aspect at the level of the antebrachio-carpal joint, insert the needle subcutaneously with the bevel up (•). Advance the needle subcutaneously and inject ( o ) adjacent to the confluence of the accessory cephalic and cephalic veins. B: 0.08 mL/kg (20%) Dorsal Branch of the Ulnar Nerve Palpate a groove between the ACb in the base of the carpal pad and the SpU. Distal to this groove, insert the needle subcutaneously with the bevel up and advance the needle proximally. Inject once the tip reaches the midpoint of the groove. C: 0.16 mL/kg (40%) Median Nerve and Superficial Branch of the Palmar Branch of the Ulnar Nerve Insert the needle subcutaneously with the bevel up lateral to the distal tip of the accessory carpal pad and advance the needle medially two-thirds the width of the limb until the tip is located near the base of the first digit. Inject two-thirds of the volume at this point and the remaining volume while withdrawing the needle (solid teal arrow). Gently massage for five seconds. D:0.02 mL/kg (5%) Deep Branch of the Palmar Branch of the Ulnar Nerve Orient the needle perpendicular to the long axis of the limb at the level of the ACb. Insert the needle subcutaneously and advance the needle laterally until it contacts the medial aspect of the ACb. Redirect the needle dorsally by rotating the needle 90 degrees. Advance it along the medial side of the ACb 2-3 mm until it penetrates the flexor retinaculum and inject. Nocita®(bupivacaine liposome injectable suspension) Resources Previous Master Detailer Download PDF Technical Monograph Download PDF Administration One Pager Download PDF See the Difference Detailer Download PDF How to Administer Nocita in Dogs Watch Video Master Detailer Download PDF Technical Monograph Download PDF Administration One Pager Download PDF See the Difference Detailer Download PDF How to Administer Nocita in Dogs Watch Video Master Detailer Download PDF Technical Monograph Download PDF Administration One Pager Download PDF See the Difference Detailer Download PDF How to Administer Nocita in Dogs Watch Video Next 1 2 3 4 5 Recovery care begins with Nocita Incorporate Nocita into your postoperative pain protocols today. Safety Information References Indication For single-dose infiltration into the surgical site to provide local postoperative analgesia for cranial cruciate ligament surgery in dogs. For use as a peripheral nerve block to provide regional postoperative analgesia following onychectomy in cats. Important Safety Information NOCITA is for use in dogs and cats only. Do not administer concurrently with bupivacaine HCl, lidocaine or other amide local anesthetics. The safe use of NOCITA in dogs and cats with cardiac disease or with hepatic or renal impairment has not been evaluated. The safe use in dogs or cats younger than 5 months of age, that are pregnant, lactating, or intended for breeding has not been evaluated. The most common adverse reactions in dogs were discharge from incision, incisional inflammation and vomiting. The most common adverse reactions in cats were elevated body temperature and infection or chewing/licking at the surgical site. Click here to view full product label. 1 Reader R, et al. Comparison of liposomal bupivacaine and 0.5% bupivacaine hydrochloride for control of postoperative pain in dogs undergoing tibial plateau leveling osteotomy. J Am Vet Med Assoc....